Phase 1 Study of SL-325 in Healthy Volunteers

Running, not enrolling · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

This first-in-human study is a randomized, double-blind, placebo-controlled, single-ascending dose and multiple-ascending dose study of SL-325 in healthy volunteers.

Key facts

Study ID
NCT07158437
Run by
Shattuck Labs, Inc.
People needed
72
Starts
2025-09-18
Expected to finish
2026-07-01
Last updated by the study team
2026-04-30

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.